BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ELEVAR THERAPEUTICS — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

ELEVAR THERAPEUTICS

via TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES)

2nd Quarter (Apr 1 - June 30) · 2024Posted Jul 22, 2024Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: ELEVAR THERAPEUTICS
Description: Biopharmaceutical company
Location: New Jersey · United States of America

Registrant

Firm: TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES)
Description: government relations
Location: Boston, Massachusetts, United States of America

Lobbying activities

1 issue

Pharmacy
General company overview.
LobbyistsLIESL GREBENSTEIN SHEEHAN
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.